Top1000 Scholar

Scholarly Index

Mien‐Chie Hung

China Medical University; 97,646 total citations; 996 total publications; best world rank #4

China Medical University

97,646Total citations
996Total publications
162H-index

Published ranking records

FieldWindowWorld rankNational rankImpact score
Biological SciencesLifetime581TW 199.93
Biological Sciences2021-2025842TW 399.08
OncologyLifetime32TW 199.94
Molecular BiologyLifetime226TW 199.90
Cancer ResearchLifetime181TW 199.00
Radiology, Nuclear Medicine and ImagingLifetime534TW 298.64
ImmunologyLifetime752TW 297.60
Cell BiologyLifetime920TW 193.61
BiotechnologyLifetime597TW 789.08
Oncology2021-2025194TW 198.48
Molecular Biology2021-2025526TW 297.29
Immunology2021-2025232TW 294.70
Cancer Research2021-2025233TW 187.27
HER2/EGFR in Cancer ResearchLifetime4TW 199.95
Monoclonal and Polyclonal Antibodies ResearchLifetime26TW 199.91
Cancer Research and TreatmentsLifetime41TW 199.53
Cancer-related Molecular PathwaysLifetime46TW 199.73
Cancer-related gene regulationLifetime44TW 199.61
Ubiquitin and proteasome pathwaysLifetime61TW 199.58
PI3K/AKT/mTOR signaling in cancerLifetime41TW 199.56
Peptidase Inhibition and AnalysisLifetime112TW 199.45
Cancer, Hypoxia, and MetabolismLifetime168TW 199.41
Epigenetics and DNA MethylationLifetime194TW 199.38
Cancer Cells and MetastasisLifetime120TW 199.38
Cancer-related molecular mechanisms researchLifetime269TW 198.96
RNA Interference and Gene DeliveryLifetime328TW 299.03
Virus-based gene therapy researchLifetime295TW 199.02
Neuroblastoma Research and TreatmentsLifetime144TW 198.96
Glycosylation and Glycoproteins ResearchLifetime365TW 498.70
Lung Cancer Treatments and MutationsLifetime383TW 599.08
Cancer Mechanisms and TherapyLifetime112TW 298.69
FOXO transcription factor regulationLifetime23TW 198.06
Cancer Immunotherapy and BiomarkersLifetime483TW 298.90
RNA modifications and cancerLifetime737TW 298.61
Cytokine Signaling Pathways and InteractionsLifetime283TW 198.31
RNA Research and SplicingLifetime642TW 398.22
NF-κB Signaling PathwaysLifetime173TW 198.11
Cell death mechanisms and regulationLifetime293TW 297.67
Signaling Pathways in DiseaseLifetime248TW 297.24
PARP inhibition in cancer therapyLifetime236TW 196.88
CAR-T cell therapy researchLifetime899TW 197.68
Protein Degradation and InhibitorsLifetime455TW 196.64
interferon and immune responsesLifetime609TW 196.37
Ferroptosis and cancer prognosisLifetime574TW 1394.52
Wnt/β-catenin signaling in development and cancerLifetime338TW 296.19
Cancer, Stress, Anesthesia, and Immune ResponseLifetime287TW 194.19
Angiogenesis and VEGF in CancerLifetime826TW 995.61
Histone Deacetylase Inhibitors ResearchLifetime593TW 494.97
Phagocytosis and Immune RegulationLifetime524TW 192.94
Kruppel-like factors researchLifetime524TW 591.41
Axon Guidance and Neuronal SignalingLifetime695TW 291.59
Hippo pathway signaling and YAP/TAZLifetime909TW 487.16
Mechanisms of cancer metastasisLifetime190TW 585.98
Cancer Immunotherapy and Biomarkers2021-2025321TW 298.75
Immunotherapy and Immune Responses2021-2025282TW 196.24
Cancer, Hypoxia, and Metabolism2021-2025222TW 494.45
Immune Cell Function and Interaction2021-2025630TW 293.31
PARP inhibition in cancer therapy2021-2025227TW 292.68
Ferroptosis and cancer prognosis2021-2025880TW 790.36
Galectins and Cancer Biology2021-2025180TW 386.25
Inflammasome and immune disorders2021-2025964TW 981.17
DNA Repair Mechanisms2021-2025934TW 278.94
Cancer-related Molecular Pathways2021-2025823TW 1173.91
Phagocytosis and Immune Regulation2021-2025579TW 372.36
Endoplasmic Reticulum Stress and Disease2021-2025957TW 870.38
Axon Guidance and Neuronal Signaling2021-2025465TW 646.20